Open AccessThe Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Author(s) -
Arturo Casadevall,
Liise Anne Pirofski,
Michael J. Joyner
Publication year - 2021
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.03372-20
Subject(s) - medicine , context (archaeology) , antibody , disease , immunology , pandemic , infectious disease (medical specialty) , antimicrobial , covid-19 , intensive care medicine , virology , biology , microbiology and biotechnology , paleontology
Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in concert with other components of the immune system.